Tumor location as a risk factor for severe immune-related adverse events
Immune-related adverse events (irAEs) can cause severe morbidity and mortality, and they impair treatment with immune checkpoint inhibitors (ICI). Risk factors for irAEs are not well understood.We observed cases of patients having tumor deposits in their liver and lung during a workup of irAEs, whic...
Saved in:
| Main Authors: | Mike Wang, Michael Dougan, Daniel Leonard, Leyre Zubiri, Ryan J Sullivan, Kerry L Reynolds, Donald P Lawrence, Kamil Slowikowski, Alexandra-Chloe Villani, Steven M Blum, Ben Ouyang, Kelley A Grealish, Nora K Hathaway, Gabriel Molina, Nishi Shah, Mari Mino Kendusen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e011312.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis
by: Michael Dougan, et al.
Published: (2020-10-01) -
Predictors of Long‐Term Survival in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis
by: Nikhil Dubey, et al.
Published: (2025-07-01) -
Job automation in China: who is at risk and where are they located?
by: Yichen Wang, et al.
Published: (2025-12-01) -
Pleomorphic Adenoma of Breast: A Radiological and Pathological Study of a Common Tumor in an Uncommon Location
by: Paula S. Ginter, et al.
Published: (2015-01-01) -
Food insecurity and barriers to supplemental food provision in the Mississippi Delta
by: Sophie Hathaway
Published: (2025-06-01)